3D Printing in Healthcare Market Overview

The global 3D printing in healthcare market is estimated to be worth over USD 10.75 Bn in 2033 and is expected to grow at CAGR of 15.7% during the forecast period (2024-2033). The method of additive manufacturing, sometimes referred to as 3D printing, produces three-dimensional solid items that are mostly employed in the healthcare industry. In order to produce 3D-printed things, additive methods are used. The additive manufacturing technique involves building up layers on top of one another in order to construct an object. The layouts appear as extremely thinly sliced layers when seen as a cross-section of the item. With the aid of this technique, customized medical tools and equipment are produced for use in the healthcare sector.

3D printing in healthcare has transformed medical practices by allowing the manufacturing of customized and intricate objects, scaling from prosthetics and implants to pharmaceuticals and anatomical models. This technology enables for patient-specific designs, mitigating surgery time and enhancing overall results. The global market for 3D printing in healthcare is spreading at a rapid pace, led by innovations in materials, greater affordability of printers, and soaring applications. Leading factors contributing to this progresscompriseprecision medicine trends, the demand for advanced medical solutions, and the continuing development of biocompatible materials, dispositioning 3D printing as a revolutionary force in the healthcare sector.

Figure 1. 3D Printing in Healthcare: Market Size

Get more details on this report - Request Free Sample

 

 

 

Key Market Insights

The 3D printing in healthcare market is experiencingnotableprogress and advancements, led by a surge in demand for precision medical solutions and innovations in additive manufacturing technology. Customization of prosthetics, implants, and medical devices, along with the capability to formcomplex anatomical models for pre-surgical planning, is accelerating the market's expansion. The growing adoption of 3D printing for drug development and pharmaceuticals is also contributing to market growth.

 

In addition to that, the continuous research and development efforts to improve biocompatible materials suitable for 3D printing applications in healthcare are defining the industry panorama. Since the technology becomes more cost-effectiveand accessible, the global market is undergoing a significantincrement, with an estimated compound annual growth rate (CAGR) reflecting a favorable future for 3D printing in transforming healthcare practices across the world.

Current Market Landscape: 3D Printing in Healthcare Offering Efficient Treatment Recourse

The current market landscape of 3D printing in healthcare is marked by dynamic innovations, growing adoption, and a multiplying of applications across the medical sphere. The technology has found extensive use in manufacturing patient-specific prosthetics, implants, and surgical models, contributing to enhancedresults and improved patient care. Remarkably, the COVID-19 pandemic has fuelled the adoption of 3D printing for the swift production of essential medical supplies, such as ventilator components and face shields, displaying the technology's versatilityand agility.

Key players in the 3D printing healthcare market involve 3D Systems Corporation, Stratasys Ltd., and Materialise NV, which have heldcritical roles in building the industry. These firmspersist to innovate and cooperate with healthcare organizations to develop up-to-date solutions. In addition to that, partnerships between pharmaceutical companies and 3D printing firms are developing, aiming on personalized medicine and drug delivery systems. The market is experiencing an upsurge in research and development activities to expand the range of biocompatible materials, further broadening the scope of 3D printing applications in healthcare. As regulatory frameworks adapt to accommodate this evolving technology, the 3D printing in healthcare market is braced for sustained growth and game-changing impact on medical practices worldwide.

Market Dynamics

Market Drivers

Increasing Demand for Personalized and Patient-Specific Medical Solutions

The competency of 3D printing technology to develop customized medical devices, implants, and prostheticscustomized to the specialized anatomical characteristics of individual patients is reforming the panorama of healthcare. This personification not only improves treatment efficiency but also reduces the risk of complications, eliminating the need for revisions and enhancing overall patient outcomes.

The rise in demand for patient-specific 3D-printed models for pre-surgical planning and training is another critical driver. Surgeons can use thorough anatomical replicas to simulate intricate procedures, growing precision and decreasing surgery time. This not only aids patient safety but also contributes to cost-effectiveness in healthcare delivery.

Along with that, the continuinginnovations in 3D printing materials, comprising biocompatible alternatives, are developing the scale of applications in the medical domain. Advancements such as 3D-printed pharmaceuticals and drug delivery systems are advancing force, opening up new horizons for the industry. As a result, the global 3D printing in healthcare market is experiencing sustained growth, encouraged by the persuasive need for personalized medical solutions, enhanced surgical results, and continuing technological advancements in additive manufacturing.

Market Restraints

With regard to numerous advantages of 3D printing in healthcare, the market faces several challenges due to the unique characteristics and requirements associated with these potent pharmaceutical products. Some of the key market challenges include:

  • Regulatory Challenges:The global 3D printing in healthcare market experiences hindrancesowing to evolving and stringent regulatory frameworks. Since the technology advances, regulatory bodies are grappling with the need to establish clear guidelines for quality assurance, standardization, and safety, which can potentially slow down the market's progress.
  • High Initial Costs: The initial investment required for 3D printing technology in healthcare, comprising the procurement of specialized printers and materials, presents a notable barrier. The high upfront costs may restrict the adoption of 3D printing solutions, specifically among smaller healthcare facilities and organizations with budget constraints, limiting the comprehensive market expansion.

Market Opportunities

Expansion of Point-Of-Care Manufacturing

A compelling market opportunity for the global 3D printing in healthcare lies in the expansion of point-of-care manufacturing. The capability of 3D printing to manufacturetailored medical devices and implants on-site, directly at healthcare facilities, poses a transformative prospect for improving patient care and reducing lead times. This approach minimizes the dependence on centralized manufacturing, streamlining the supply chain and mitigating logistical challenges. Point-of-care 3D printing empowers healthcare providers to swiftly respond to patient needs, deliveringcustomized solutions with decreased waiting times. This opportunity not only improves the efficiency of healthcare delivery but also addresses the soaring demand for personalized medical interventions. As technology persists to advance and regulatory frameworks adapt, the union of point-of-care 3D printing in healthcare presents a promising avenue for industry growth and enhanced patient outcomes across the globe.

Market Trends

Expanding Applications in Pharmaceuticals:A notable trend in the global 3D printing in healthcare market is the increasing exploration of applications in pharmaceuticals. This includes the development of 3D-printed drug formulations and personalized medicine, allowing for precise dosage and tailored treatment plans. Pharmaceutical companies are leveraging 3D printing to enhance drug delivery systems, promising a more efficient and patient-centric approach to medication.

3D Printing in Healthcare Market: Key Segments

By Component

  • System
  • Materials
    • Polymers
      • Photopolymers
      • Thermoplastics
    • Metals & Alloys
    • Ceramics
    • Others
  • Services

By Technology

  • Droplet Deposition  
    • Fused Filament Fabrication (FFF) Technology
    • Low-temperature Deposition Manufacturing (LDM)
    • Multiphase Jet Solidification (MJS)
  • Photopolymerization
    • Stereolithography (SLA)
    • Continuous Liquid Interface Production (CLIP)
    • Two-photon Polymerization (2PP)
  • Laser Beam Melting 
    • Selective Laser Sintering (SLS)
    • Selective Laser Melting (SLM)
    • Direct Metal Laser Sintering (DMLS)
  • Electronic Beam Melting (EBM)    
  • Laminated Object Manufacturing  
  • Others
    • Color Jet Printing
    • MultiJet Printing

By Application

  • External Wearable Devices 
    • Hearing Aids
    • Prosthesis & Orthotics
    • Dental Products
  • Clinical Study Devices       
    • Drug Testing
    • Anatomical Models
  • Implants     
    • Surgical Guides
    • Cranio-maxillofacial Implants
    • Orthopedic Implants
  • Tissue Engineering 

By End User

  • Medical & Surgical Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutions

By Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America

3D Printing in Healthcare Market: Segmental Analysis

By component, the global 3D printing in healthcare market is categorized into system, materials and services. The system segment dominates the 3D printing in healthcare market. Moreover, several technological advancements, such as multi-material, full colour 3D printers that are solar powered & portable in nature, drive the growth of the 3D printing in healthcare market.

By end user, the 3D printing in healthcare market is segmented into medical & surgical centers, pharmaceutical & biotechnology companies, and academic institutions. The medical & surgical centers segment held the largest market share in 2020 and is expected to remain dominant during the forecast period. Various factors driving the growth of the 3D printing in healthcare market include augmented investments in 3D printing technologies by government & private bodies, increase in collaborations between academic institutes & companies. These factors have opened avenues for the growth of the 3D printing in healthcare market.

3D Printing in Healthcare Market: Regional Analysis

North America is expected to maintain its dominance during the forecast period due to the three major countries of North America considered in the report include the U.S., Canada, and Mexico. North America is dominating the market of overall 3D printing in healthcare and expected to dominate throughout the forecast period. This is attributed to widespread adoption of 3D printing technology and numerous collaborations between academic and commercial organizations in this region.

Figure 4. 3D Printing in Healthcare Market: Distribution by Region

Get more details on this report - Request Free Sample

Leading 3D Printing in Healthcare Developers

Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the 3D Printing in Healthcaremarket, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the biopharmaceutical industry. Key takeaways of the 3D Printing in Healthcaremarket are briefly discussed below.

The report includes the list of players operating in the global 3D printing in healthcare market. Some of the key players include:

  • 3D Systems Corporation
  • Exone Company
  • Formlabs Inc.
  • General Electric,
  • Materialise NV
  • Oxferd Performance Materials, Inc.
  • Organovo Holdings, Inc.
  • Proto Labs
  • SLM Solutions Group AG
  • Stratasys Ltd

Recent Developments in the 3D Printing in Healthcare Market

Several recent developments have taken place in the field of 3D Printing in Healthcare, some of which have been outlined below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we’ve outlined in our analysis. chronologically

  • In 2021, Stratasys Ltd. unveiled a J5 DentaJet 3D Poly Jet printer for dental facilities.
  • In 2020, Canwell Medical and SLM Solutions collaborated. Canwell Medical will be able to employ SLM equipment to create 3D printed surgical implant items as a result of this collaboration. Canwell Medical will get application and technical help, as well as research and development support, as it moves closer to serial production and product certification.
  • In 2020, Siemens Healthineers acquired approximately US$ 16.4 billion for Varian Medical Technologies, Inc. The acquisition aimed to integrate separate firms' 3D printing assets while boosting the company's overall market position.

Scope of the Report

The market report presents an in-depth analysis of the various firms / organizations that are engaged in this market, across different segments, as defined in the below table:

Key Report Attributes

Details

Base Year

2023

Forecast Period

2024-2033

CAGR (2024-2033)

   15.7%

Component

  • System
  • Materials
    • Polymers
      • Photopolymers
      • Thermoplastics
    • Metals & Alloys
    • Ceramics
    • Others
  • Services

Technology

  • Droplet Deposition  
    • Fused Filament Fabrication (FFF) Technology
    • Low-temperature Deposition Manufacturing (LDM)
    • Multiphase Jet Solidification (MJS)
  • Photopolymerization
    • Stereolithography (SLA)
    • Continuous Liquid Interface Production (CLIP)
    • Two-photon Polymerization (2PP)
  • Laser Beam Melting 
    • Selective Laser Sintering (SLS)
    • Selective Laser Melting (SLM)
    • Direct Metal Laser Sintering (DMLS)
  • Electronic Beam Melting (EBM)    
  • Laminated Object Manufacturing  
  • Others
    • Color Jet Printing
    • MultiJet Printing

Application

  • External Wearable Devices 
    • Hearing Aids
    • Prosthesis & Orthotics
    • Dental Products
  • Clinical Study Devices       
    • Drug Testing
    • Anatomical Models
  • Implants     
    • Surgical Guides
    • Cranio-maxillofacial Implants
    • Orthopedic Implants
  • Tissue Engineering 

End User

  • Medical & Surgical Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutions

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Key Companies Profiled

  • 3D Systems Corporation
  • Exone Company
  • Formlabs Inc.
  • General Electric,
  • Materialise NV
  • Oxferd Performance Materials, Inc.
  • Organovo Holdings, Inc.
  • Proto Labs
  • SLM Solutions Group AG
  • Stratasys Ltd

 

 

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.